Oruka Therapeutics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On February 2, 2024, Raymond L. Woosley, M.D., Ph.D. and Dan Mitchell each resigned from the board of directors (the “ Board ”) of ARCA biopharma, Inc., a Delaware corporation (“ ARCA ”), effective immediately.
On February 2, 2024, Raymond L. Woosley, M.D., Ph.D. and Dan Mitchell each resigned from the board of directors (the “ Board ”) of ARCA biopharma, Inc., a Delaware corporation (“ ARCA ”), effective immediately.
Extracted from this filing and checked against the source text.
Raymond L. Woosley resigned as director at Oruka Therapeutics, Inc..
On February 2, 2024, Raymond L. Woosley, M.D., Ph.D. and Dan Mitchell each resigned from the board of directors (the “ Board ”) of ARCA biopharma, Inc., a Delaware corporation (“ ARCA ”), effective immediately.View on SEC.gov
Dan Mitchell resigned as director at Oruka Therapeutics, Inc..
On February 2, 2024, Raymond L. Woosley, M.D., Ph.D. and Dan Mitchell each resigned from the board of directors (the “ Board ”) of ARCA biopharma, Inc., a Delaware corporation (“ ARCA ”), effective immediately.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.